期刊
VACCINE
卷 28, 期 21, 页码 3748-3753出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2009.10.025
关键词
HSV vaccine; Adjuvant; Genital herpes; Guinea pig; CLDC
资金
- NIH/NIAID (National Institute of Health) [AI 15438]
Herpes simplex virus (HSV) infections are common but there is no vaccine available. We evaluated cationic liposorne-DNA complexes (CLDC) as an adjuvant for an HSV gD2 vaccine and compared it to an MPL/Alum adjuvant in a guinea pig model of genital herpes. The addition of CLDC to the gD2 vaccine significantly decreased acute and recurrent disease and most importantly the number of days with recurrent virus shedding compared to gD2 alone. Reductions in these outcomes were also detected when gD2 + CLDC was compared to gD2 + MPL/Alum. When the vaccine and adjuvants were evaluated as therapeutic vaccines, they were ineffective. CLDC enhanced protection compared to MPL/Alum and is the first vaccine to reduce recurrent virus shedding, a key to decreasing the spread of HSV-2. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据